Get started
Ono Pharmaceutical Co., Ltd. Unsponsored ADROno Pharmaceutical Co., Ltd. Unsponsored ADROno Pharmaceutical Co., Ltd. Unsponsored ADR

Ono Pharmaceutical Co., Ltd. Unsponsored ADR

No trades
See on Supercharts
OverviewFinancialsNewsDiscussionsForecastSeasonals

A2N6NC chart


Full chart

A2N6NC upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.59 B‬ EUR
Dividend yield (indicated)
2.93%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
0.1750 EUR
Net income (FY)
‪303.45 M‬ EUR
Revenue (FY)
‪2.95 B‬ EUR
Shares float
—
Beta (1Y)
−0.19

About ONO Pharmaceutical Co., Ltd.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Gyo Sagara
Website
ono.co.jp
Headquarters
Osaka
Founded
1947
ISIN
US6827361030
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Check out other big names from the same industry as A2N6NC.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

A2N6NC news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.